Richard D. Gill
Directeur/Bestuurslid bij Cognoptix, Inc.
Profiel
Richard D.
Gill currently works at Cognoptix, Inc., as Director and Lovelace Respiratory Research Institute, as Director.
Dr. Gill also formerly worked at Sierra Oncology, Inc., as President & Chief Executive Officer, TruTouch Technologies, Inc., as President, Chief Executive Officer & Director from 2011 to 2013, BioLegend CNS, Inc., as President & Chief Executive Officer, ActiveCyte, Inc., as President & Chief Executive Officer, AnVil, Inc., as President & Chief Executive Officer, SynDevRx, Inc., as Director, NABsys, Inc., as Director, Launchpad Venture Group LLC, as Director, Era Biotech SA, as Director, Oscient Pharmaceuticals Corp., as President & Chief Operating Officer, Unilever Plc, as Principal, BTG International, Inc., as Senior Vice President & General Manager, and Rittenhouse Ventures LLC, as Advisor.
Dr. Gill received his undergraduate degree and doctorate degree from The University of Reading.
Actieve functies van Richard D. Gill
| Bedrijven | Functie | Begin |
|---|---|---|
Cognoptix, Inc.
 Cognoptix, Inc. Hospital/Nursing ManagementHealth Services Cognoptix, Inc. develops a non-invasive and predictive eye scanning test for the early detection and diagnosis of alzheimer's disease. It offers technologies to enable non-invasive quantitative measurements of amyloid aggregates in the eye. The firm also develops combined optical scanning devices and diagnostic agents for clinical, commercial and academic research use. The company was founded by Lee E. Goldstein and Leo T. Chylack Jr in 2001 and is headquartered in Acton, MA. | Directeur/Bestuurslid | - |
Lovelace Respiratory Research Institute
 Lovelace Respiratory Research Institute Miscellaneous Commercial ServicesCommercial Services Lovelace Respiratory Research Institute provides biomedical research services. It conducts research and development of countermeasures to chemical, biological, nuclear, radiological, and explosive emerging and environmental threats to human health as well as advancing the diagnosis and treatment of mental illness and other brain disorders. The company was founded in 1947 and is headquartered in Albuquerque, NM. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Richard D. Gill
| Bedrijven | Functie | Einde |
|---|---|---|
Rittenhouse Ventures LLC
 Rittenhouse Ventures LLC Investment ManagersFinance Rittenhouse Ventures LLC (Rittenhouse Ventures) is a venture capital firm founded in 2006 by Saul Richter and Bruce Luehrs. The firm is headquartered in Philadelphia, Pennsylvania. | Private Equity Investor | 30-04-2008 |
SynDevRx, Inc.
 SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Directeur/Bestuurslid | - |
NABsys, Inc.
 NABsys, Inc. Miscellaneous Commercial ServicesCommercial Services NABsys, Inc. developed DNA analysis sequencing platform. Its platform used solid-state nanodetectors to analyze single DNA molecules, revealing both location and identity of DNA sequences over long distances. The firm system was designed to set new standards for accuracy, speed and scalability, offering compelling advantages for the analysis of genome structural variation, genome mapping, and both targeted and whole genome sequencing. The company was founded by Xinsheng Sean Ling, Leon N. Cooper and Barrett Bready in 2004 and was headquartered in Providence, RI. | Directeur/Bestuurslid | - |
| UNILEVER PLC | Corporate Officer/Principal | - |
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | President | - |
Opleiding van Richard D. Gill
| The University of Reading | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| UNILEVER PLC | Consumer Non-Durables |
| Bedrijven in privébezit | 14 |
|---|---|
Rittenhouse Ventures LLC
Rittenhouse Ventures LLC Investment ManagersFinance Rittenhouse Ventures LLC (Rittenhouse Ventures) is a venture capital firm founded in 2006 by Saul Richter and Bruce Luehrs. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
Launchpad Venture Group LLC
 Launchpad Venture Group LLC Investment ManagersFinance Launchpad Venture Group LLC (Launchpad Venture Group) is a venture capital firm founded in 2001 by Rick Lucash. The firm is headquartered in Newton, Massachusetts. | Finance |
BioLegend CNS, Inc.
 BioLegend CNS, Inc. BiotechnologyHealth Technology BioLegend CNS, Inc. provides monoclonal antibodies used in the research of cancer, infectious disease and neurodegenerative diseases. The company is headquartered in Boston, MA. | Health Technology |
BTG International, Inc.
 BTG International, Inc. Investment ManagersFinance BTG International Inc. (BTG International) is a venture capital subsidiary of BTG Ltd founded in 1981. The firm is headquartered in West Conshohocken, Pennsylvania. | Finance |
Era Biotech SA
 Era Biotech SA Miscellaneous Commercial ServicesCommercial Services Era Biotech SA is a biotechnology company that specializes in enzymes and recombinant vaccines. It develops and produces vaccines for human and animal health, therapeutic peptides, and industrial enzymes. The company was founded in August 2002 and is headquartered in Barcelona, Spain. | Commercial Services |
TruTouch Technologies, Inc.
 TruTouch Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services TruTouch Technologies, Inc. develops, manufactures, and sells versatile noninvasive alcohol testing systems for both existing and emerging markets. It provides TruTouch system, an alcohol deterrence detection system, which is used in workforce workplace safety, medical diagnostic, alcohol point-of-sale liability reduction, law enforcement, and industrial safety sectors. The company was founded by Trent Daniel Ridder and Benjamin J. Ver Steeg on September 6, 2005 and is headquartered in Albuquerque, NM. | Commercial Services |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
| AnVil, Inc. | |
| ActiveCyte, Inc. | |
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Commercial Services |
NABsys, Inc.
NABsys, Inc. Miscellaneous Commercial ServicesCommercial Services NABsys, Inc. developed DNA analysis sequencing platform. Its platform used solid-state nanodetectors to analyze single DNA molecules, revealing both location and identity of DNA sequences over long distances. The firm system was designed to set new standards for accuracy, speed and scalability, offering compelling advantages for the analysis of genome structural variation, genome mapping, and both targeted and whole genome sequencing. The company was founded by Xinsheng Sean Ling, Leon N. Cooper and Barrett Bready in 2004 and was headquartered in Providence, RI. | Commercial Services |
SynDevRx, Inc.
SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Commercial Services |
Cognoptix, Inc.
Cognoptix, Inc. Hospital/Nursing ManagementHealth Services Cognoptix, Inc. develops a non-invasive and predictive eye scanning test for the early detection and diagnosis of alzheimer's disease. It offers technologies to enable non-invasive quantitative measurements of amyloid aggregates in the eye. The firm also develops combined optical scanning devices and diagnostic agents for clinical, commercial and academic research use. The company was founded by Lee E. Goldstein and Leo T. Chylack Jr in 2001 and is headquartered in Acton, MA. | Health Services |
Lovelace Respiratory Research Institute
Lovelace Respiratory Research Institute Miscellaneous Commercial ServicesCommercial Services Lovelace Respiratory Research Institute provides biomedical research services. It conducts research and development of countermeasures to chemical, biological, nuclear, radiological, and explosive emerging and environmental threats to human health as well as advancing the diagnosis and treatment of mental illness and other brain disorders. The company was founded in 1947 and is headquartered in Albuquerque, NM. | Commercial Services |
